Accession Number: | 0001169245-20-000016 |
Date: | 2020-02-12 |
Issuer: | PHASEBIO PHARMACEUTICALS INC (PHAS) |
Original Submission Date: |
BURKHARDT GLEN
C/O PHASEBIO PHARMACEUTICALS, INC.
1 GREAT VALLEY PARKWAY, SUITE 30
MALVERN, PA 19355
Title of Security | Transaction Date | 2a. Deemed Execution Date | Transaction Code | Shares | Acquired or Disposed | Price per share | 5. Amount of Securities Beneficially Owned Following Reported Transaction | 6. Ownership Form Direct or Indirect | Nature of Indirect Ownership |
---|
Title of Derivative Security | Conversion or Exercise Price of Derivative Security | Transaction Date | Deemed Execution Date | Transaction Code | Number of Derivative Securities Acquired (A) or Disposed of (D) | Date Exercisable | Expiration Date | Title and Amount of Securities Underlying Derivative Security | Price of Derivative Security | Number of derivative Securities Beneficially Owned Following Reported Transaction(s) | Ownership Form: Direct (D) or Indirect (I) | Nature of Indirect Beneficial Ownership |
---|---|---|---|---|---|---|---|---|---|---|---|---|
EMPLOYEE STOCK OPTION (RIGHT TO BUY) | 5.19 | 2020-02-12 | deemed execution date | A | 55,000 (a) | 2030-02-12 | common stock 55,000 | $5.19 | 55,000 | direct | ||
EMPLOYEE STOCK OPTION (RIGHT TO BUY) | 5.19 | 2020-02-12 | deemed execution date | A | 20,000 (a) | 2030-02-12 | common stock 20,000 | $5.19 | 20,000 | direct |
ID | footnote |
---|---|
f1 | the shares subject to the option shall vest in equal monthly installments over 48 months from february 12, 2020, subject to the reporting person's continued service through each such date. |
f2 | one-fourth (1/4th) of the shares vest one year after the initial vesting date of march 15, 2019; the balance of the shares shall vest in a series of 36 successive equal monthly installments measured from the first anniversary of the initial vesting date, subject to the reporting person's continuous service as of each such date. |